SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The bureau “may recommend suing drug manufacturers” in the future, the FTC said. Insulin, a hormone produced by the pancreas, helps the body control blood-sugar levels. For people with diabetes, a ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Increasing demand for erythropoietin drugs in veterinary medicine for treating anemia in animals.Wilmington, Delaware, United ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

Eli Lilly and Company LLY announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for ...